A Study of ALG-010133 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects
Clinical trial NCT04485663 · TERMINATED
Trial details
- NCT number
- NCT04485663
- Sponsor
- Aligos Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-17
- Primary completion
- 2022-03-08
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.